"If we add that RMB27.9 million convertible notes interest expense and RMB4.7 million convertible notes issuance costs, to the non-GAAP adjusted income from continuing operation of RMB119.4 million and divide it by 36.2 million ADS, the adjusted EPS from continuing operation would be RMB4.20 or US$0.62."
So, if we take convertible bond fully converted to common shares, the impact on EPS is 5 cents.
Again, stop scaring investors on PIPE talk, you disgusting asses. If CMED can't run the company to our expectation, that's our investors' fate. But please do not try to sidetrack our attention to non-existing issue.